Cresilon

Saving Lives

New York, United States · Founded 2010 · $63.5M raised

Headquarters
New York, New York
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$63.5M
Last Round
$25.0M Extension RoundOct 2022
Rounds
2

About

Cresilon is a Brooklyn-based medical device company developing plant-based hemostatic gel technologies for veterinary and human wound care. Its proprietary products include VETIGEL for veterinary procedures and TRAUMAGEL for controlling moderate to severe external traumatic bleeding in people. Founded to manufacture an adhesive gel that supports natural clotting, Cresilon operates a GMP-certified Brooklyn facility and focuses on improving wound care and advancing medical treatment standards.

Summary

Cresilon is a Biotech company based in New York, United States, founded in 2010. It has raised $63.5M in total across 2 rounds, most recently a $25.0M Extension Round round in Oct 2022.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A-4Oct 2022
$25.0M

Sign up to see all 2 rounds

Extension Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cresilon on Indexed.vc
<a href="https://indexed.vc/companies/cresilon"><img src="https://indexed.vc/api/badge/company/cresilon" alt="Cresilon on Indexed.vc" width="260" height="76" /></a>